Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma

Cancer Letters

Volumn 111, Issue 1-2, 1997, Pages 191-197

  Furutani, Masaharu ^a   Arii, Shigeki ^a   Tanaka, Hisashi ^a   Mise, Masahiro ^a   Niwano, Mototaka ^a   Harada, Tomika ^a   Higashitsuji, Hiroaki ^a   Imamura, Masayuki ^a   Fujita, Jun ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

CIP1; Cyclin dependent kinase; Hepatocellular carcinoma; p21; p53; WAF1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; MALE; MUTATION RATE; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOWN-REGULATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER;

EID: 0031025745     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04509-0     Document Type: Article

References (41)

1. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers, Science, 253, 49-53.
2. Vogelstein, B. and Kinzler, K.W. (1992) p53 function and dysfunction, Cell, 70, 523-526.
3. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osbome, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes, Nature, 362, 847-849.
4. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, ML. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature, 362, 849-852.
5. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell, 75, 805-816.
6. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817-825.
7. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases, Nature, 366, 701-704.
8. 1 arrest and apoptosis, Cancer Res., 54, 1169-1174.
9. Eastham, J.A., Hall, S.J., Sehgal, I., Wang, J., Timme, T.L., Yang, G., Connell-Crowley, L., Elledge, S.J., Zhang, W.W., Harper, J.W. and Thompson, T.C. (1995) In vivo gene therapy with p53 or p21 adenovirus for prostate cancer, Cancer Res., 55, 5151-5155.
10. Yang, Z.Y., Perkins, N.D., Ohno, T., Nabel, E.G. and Nabel, G.J. (1995) The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo, Nature Med., 1, 1052-1056.
11. Nishida, N., Fukuda, Y. and Ishizaki, K. (1994) Molecular aspects of hepatocarcinogenesis and their clinical implications (review), Int. J. Oncol., 4, 615-622.
12. Liver Cancer Study Group of Japan (1992) The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 3rd edn., pp. 22-23. Kanehara Press, Tokyo.
13. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162, 156-159.
15. Furutani, M., Arii, S., Higashitsuji, H., Mise, M., Fukumoto, M., Takano, S., Nakayama, H., Imamura, M. and Fujita, J. (1995) Reduced expression of kan-1 (encoding putative bile acid-CoA-amino acid N-acyltransferase) mRNA in livers of rats after partial hepatectomy and during sepsis, Biochem J., 311, 203-208.
16. Marchuk, D., Drumm, M., Saulino, A. and Collins, F.S. (1991) Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products, Nucleic Acids Res., 19, 1154.
17. Kaneko, Y., Takano, S., Okumura, K., Takenawa, J., Higashitsuji, H., Fukumoto, M., Nakayama, H. and Fujita, J. (1993) Identification of protein tyrosine phosphatases expressed in murine male germ cells, Biochem. Biophys. Res. Commun., 197, 625-631.
18. Furutani, M., Arii, S., Monden, K., Adachi, Y., Funaki, N., Higashitsuji, H., Fujita, S., Mise, M., Ishiguro, S., Kitao, T., Nakamura, T., Imamura, M., Tamatani, T., Miyasaka, M., Nakayama, H. and Fujita, J. (1994) Immunologic activation of hepatic macrophages in septic rats: a possible mechanism of sepsis-associated liver injury, J. Lab. Clin. Med., 123, 430-436.
19. Orita, M., Suzuki, Y., Sekiya, T. and Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction, Genomics, 5, 874-879.
20. Wagata, T., Shibagaki, I., Imamura, M., Shimada, Y., Toguchida, J., Yandell, D.W., Ikenaga, M., Tobe, T. and Ishizaki, K. (1993) Loss of 17p, mutation of the p53 gene and overexpression of p53 protein in esophageal squamous cell carcinomas, Cancer Res, 53, 846-850.
21. Marchetti, A., Doglioni, C., Barbareschi, M., Buttitta, F., Pellegrini, S., Bertacca, G., Chella, A., Merlo, G., Angeletti, C.A., Palma, P.D. and Bevilacqua, G. (1996) p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation, Oncogene, 12, 1319-1324.
22. 1 cyclin-dependent kinases, Genes Dev., 9, 1149-1163.
23. WAF1/CIP1 expression in normal and neoplastic tissues, Cancer Res., 55, 2910-2919.
24. DiGiuseppe, J.A., Redston, M.S., Yeo, C.J., Kern, S.E. and Hruban, R.H. (1995) p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma, Am. J. Pathol., 147, 884-888.
25. Wang, X.W., Gibson, M.K., Vermeulen, W., Yen, H., Forrester, K., Stürzbechter, H.W., Hoeijmakers, J.H.J. and Harris, C.C. (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene, Cancer Res., 55, 6012-6016.
26. Ueda, H., Ullrich, S.J., Gangemi, J.D., Kappel, C.A., Ngo, L., Feitelson, M.A. and Jay, G. (1995) Functional inactivation but not structural mutation of p53 causes liver cancer, Nature Genet., 9, 41-47.
27. Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W. and Vogelstein, B. (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53, Nature, 362, 857-860.
28. Michieli, P., Chedid, M, Lin, D., Pierce, J.H., Mercer, W.E. and Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway, Cancer Res., 54, 3391-3395.
29. Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L., Bast, R.C.J., Iglehart, J.D. and Marks, J.R. (1994) Transforming growth factor β1can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells, Cell Growth Differ., 5, 1301-1307.
30. Osawa, Y., Hachiya, M., Koeffler, H.P., Suzuki, G. and Akashi, M. (1995) IL-1 induces expression of WAF1 mRNA in human fibroblasts: mechanisms of accumulation, Biochem. Biophys. Res. Commun., 216, 429-437.
31. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D. and Lassar, A.B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD, Science, 267, 1018-1021.
32. Skapek, S.X., Rhee, J., Spicer, D.B. and Lassar, A.B. (1995) Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase, Science, 267, 1022-1024.
33. Russo, T., Zambrano, N., Esposito, F., Ammendola, R., Cimino, F., Fiscella, M., Jackman, J., O'Connor, P.M., Anderson, C.W. and Appella, E. (1995) A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress, J. Biol. Chem., 270, 29386-29391.
34. WAF1/CIP1 in breast epithelial cells, Cancer Res., 55, 4520-4524.
35. Watanabe, H., Fukuchi, K., Takagi, Y., Tomoyasu, S., Tsuruoka, N. and Gomi, K. (1995) Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors, Biochim. Biophys. Acta, 1263, 275-280.
36. Gao, X., Chen, Y.Q., Wu, N., Grignon, D.J., Sakr, W., Porter, A.T. and Honn, K.V. (1995) Somatic mutations of the WAF1/ CIP1 gene in primary prostate cancer, Oncogene, 11, 1395-1398.
37. Shiohara, M., El-Deiry, W.S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D.L., Vogelstein, B. and Koeffler, H.P. (1994) Absence of WAF1 mutations in a variety of human malignancies, Blood, 84, 3781-3784.
38. Li, Y.J., Laurem-Puig, P., Salmon, R.J., Thomas, G. and Hamelin, R. (1995) Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer, Oncogene, 10, 599-601.
39. Koopmann, J., Maintz, D., Schild, S., Schramm, J., Louis, D.N., Wiestier, O.D. and von Deimling, A. (1995) Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours, Br. J. Cancer, 72, 1230-1233.
40. CKI gene in malignant gliomas, Int. J. Cancer, 62, 115-117.
41. Mousses, S., Ozçelik, H., Lee, P.D., Malkin, D., Bull, S.B. and Andrulis, I.L. (1995) Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer, Hum. Mol. Genet., 4, 1089-1092.